The world’s largest health-care company says U.S. patients may avoid buying their medications if they see the prices in television ads.
A proposal from the Trump administration that would force drugmakers to disclose the list price of any medication that costs more than $35 could discourage some from seeking treatment, executives from Johnson & Johnson said on an earnings conference call Oct. 16.
List prices on TV ads “could be somewhat confusing and actually act as a deterrent to good, responsible health care and we just want to make sure that that doesn’t play out that way,” J&J Chief Financial...
For more stories, analysis and expertiseOR Request Trial
(Updates with HHS secretary comment in sixth, 10th, and 11th paragraphs.)